227 studies found for:    Open Studies | "Thyroid Diseases"
Show Display Options
Rank Status Study
21 Recruiting Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
Conditions: Thyroid Associated Ophthalmopathies;   Graves´ Ophthalmopathy;   Thyroid Eye Disease
Interventions: Drug: Tocilizumab (RoActemra®);   Drug: Sterile 0.9% Sodium Chloride
22 Recruiting Collaborative Registry of Patients With Thyroid Cancer and/or Thyroid Tumors
Condition: Neoplasms, Thyroid
23 Recruiting The Reduced Thyroid Function of the Premature Newborn: Relation With Molecular Changes in the Placenta and Maternal Thyroid Hormone Status and Neurodevelopmental Implications
Condition: Thyroid Metabolism
24 Recruiting Radiofrequency Ablation in Thyroid Nodules
Condition: Thyroid Nodules
Intervention: Procedure: Radiofrequency ablation of the thyroid nodule
25 Not yet recruiting Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients
Condition: Thyroid Carcinoma
Intervention: Drug: Sorafenib (Nexavar,BAY43-9006)
26 Recruiting Diagnostic Value of Molecular Cytological Analysis (CMA) and Shear Wave Elastography ShearWave (SWE) in Patients With a Thyroid Nodule With Indeterminate Cytology: Feasibility Study
Conditions: Thyroid Node;   Indeterminate Cytology;   Surgery Indication
Intervention: Procedure: aspiration in thyroid node for Molecular Cytogenetic Analysis.
27 Unknown  Effect of Carum Carvi on Thyroid Hormones and TSH Level
Condition: Thyroid Cancer Patients
Interventions: Drug: Carum Cravi;   Drug: Placebo
28 Recruiting Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
Conditions: Healthy;   Pituitary Disease;   Thyroid Disease
Intervention: Drug: TRH (Thyrotropin Releasing Hormone)
29 Recruiting Thyroid Disease Serum Repository
Condition: Thyroid Disease
30 Recruiting IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
Condition: Thyroid Cancer
Intervention: Radiation: I131 1.1 GBq
31 Recruiting Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
Condition: Non-Medullary Thyroid Cancer
32 Recruiting Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
Condition: Thyroid Cancer
Interventions: Drug: Vemurafenib (All Groups);   Drug: Vemurafenib (Post Surgery) - Group A + C;   Other: Post Surgery - Group B
33 Unknown  Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: Recombinant thyrotropin
34 Recruiting Realtime-Elastography (RTE) and Thyroid Nodules
Condition: Thyroid Nodules
Interventions: Device: Realtime-Elastography, linear ultrasound probe, Hitachi EUB-900, Japan;   Procedure: Cytology (FNAB) or Surgery
35 Unknown  Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: pemetrexed + paclitaxel
36 Unknown  A Prospective Randomized Equivalence Trial to Evaluate the Safety of the Ligasure in Thyroid Surgery
Conditions: Multinodular Goitre;   Grave's Disease;   Thyroid Nodule
Intervention: Device: Ligasure Device
37 Not yet recruiting Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Interventions: Drug: Fosbretabulin + paclitaxel + carboplatin;   Drug: Placebo + paclitaxel + carboplatin
38 Unknown  Redifferentiation Therapy Using Alpha Lipoic Acid in Thyroid Cancer
Conditions: Thyroid;   Cancer
Intervention: Drug: alpha-lipoic acids
39 Recruiting A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Intervention: Biological: GI-6207
40 Recruiting Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
Condition: Papillary Thyroid Carcinoma
Intervention: Drug: GSK2118436

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years